Return to search

Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness /

Thesis (Ph. D.)--University of Texas at Austin, 2004. / Supervisors: Karen L. Rascati and James P. Wilson. Vita. Includes bibliographical references. Also available from UMI.

Identiferoai:union.ndltd.org:OCLC/oai:xtcat.oclc.org:OCLCNo/57663420
Date January 2004
CreatorsTiller, Kevin Wade, Rascati, Karen L., Wilson, James P.,
Source SetsOCLC
LanguageEnglish
Detected LanguageEnglish

Page generated in 0.0017 seconds